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Summary Computed tomographic scanning of the chest in 100 patients with newly diagnosed malignant
lymphoma detected mediastinal lymphadenopathy (39%) and parenchymal deposits (15%) with a significantly
greater sensitivity and specificity than conventional radiological techniques. This principally affected the
staging and treatment of patients with limited stage disease. The stage was changed in 10/61 patients (16%)
with Stages I-III prior to CT scan and treatment was altered in 11/29 (38%) patients for whom radiation was
the treatment of choice. Complete remissions as defined by CT scan have been more durable than those
defined by CXR alone.
The successful management of patients with
malignant lymphoma is dependent upon accurate
staging and an appropriate treatment regime.
Although the chest is a frequent site of involvement
(Chabner, 1977; Filly et al., 1976; Kaplan, 1980;
Peckham, 1973; Rosenberg, 1961), investigation
has relied upon the plain chest X-ray (CXR) and
tomography (Tomo) until the introduction of com-
puted tomographic scanning (CT scan).
Prognosis has been found to correlate with the
presence of very bulky disease in the chest, and
even moderate amounts of intrathoracic lymphoma
have been associated with a worse response to
treatment than would be expected for other sites of
involvement (Lee et al., 1980; Mauch et al., 1978).
CT has been found to detect more mediastinal and
pulmonary disease (Fong et al., 1982; Muhm et al.,
1979; Osbourne et al., 1982; Underwood et al.,
1979) in patients with thymoma and bronchial
carcinoma, and it has been suggested that it may
improve the staging of intrathoracic lymphoma
(Ellert & Kreel, 1980). Comparison has not
previously been made with conventional radio-
graphy, therefore a prospective study was under-
taken to determine the role of thoracic CT in the
management ofpatients with lymphoma.
Patients and methods
Patients
One hundred consecutive, previously untreated
Table I Patients
HD NHL
Number 37 63
Median age 40 years 52 years
Sex ratio M:F 17:20 37:26
Stage I 4 14
II 15 7
III 9 7
IV 9 35
Histology LP 5 Follicular 17
NS 25 Diffuse low grade 27
MC 6 Diffuse high grade 19
LD 1
LP=Lymphocyte predominant; NS=Nodular
sclerosing; MC=Mixed cellularity; LD=Lymphocyte
depleted.
patients with biopsy proven malignant lymphoma
were studied over an 18-month period (Table I).
The histological diagnosis was established in all
cases by Dr A.G. Stansfeld and the patients were
staged by the modified Ann Arbor convention
(Smithers & Tubiana, 1971) as previously described
(Lister et al., 1978; Sutcliffe et al., 1978). All
patients were treated according to the current
protocols of the Imperial Cancer Research Fund
Department of Medical Oncology and the
Department of Radiotherapy at St Bartholomew's
Hospital, London. Response was assessed with full
restaging one month after the completion of
treatment.
Radiology
The first 50 patients were investigated as follows:
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(a) Chest X-ray: posteroanterior (PA), lateral and
penetrated PA views.
(b) Tomograms: PA and lateral tomograms of the
mediastinum and hila at 1 cm intervals.
(c) CT scan: CT scan was performed with
contiguous 1.3cm sections from the sternal notch
to the diaphragm using an EMI 5005 CT body
scanner. Intravenous contrast was given to 14
patients to enhance the major vessels when findings
were equivocal by plain scan.
In the second half of the study a further 50
patients were examined by PA, penetrated and
lateral CXR and CT scan only. For these patients
the CT scan included the lung bases only when
abnormalities were present in the upper part of the
chest (19/50).
Follow up
At the completion of treatment all patients were re-
examined with repeat PA, lateral and penetrated
CXR. CT scan was repeated in all those in whom it
was previously abnormal or equivocal.
All patients have had monthly clinical follow up
for 24-42 months from the completion of
treatment, with further CXRs and CT scans.
Analysis
At the completion of the study the CXR and
tomograms (AKT) and CT scans (IKF, FEW) were
reported independently. All cases in which the
findings differed were then reviewed together with
the X-rays taken following treatment and with the
knowledge of the patient's clinical course and
response to therapy.
Soft tissue masses in the mediastinal and hilar
regions were reported as lymphadenopathy. Paren-
chymal lymphoma was only diagnosed in the
presence of discrete nodules or infiltrates and in the
absence of clinical evidence of infection. Histo-
logical confirmation of parenchymal lymphomas
was achieved in 6 patients. Shadows radiating from
the hila were not accepted as evidence of
lymphomatous infiltration as they could not be
distinguished from vascular or lymphatic
congestion. Equivocal findings were recorded as
negative and post radiation fibrosis was
disregarded.
Statistical analysis was made using the Chi
squared test with Yates' correction and Student's
t test.
Definitions
True positive abnormalities Those confirmed histo-
logically (15 patients), and those showing resolution
on repeat examination following successful
lymphoma treatment without antibiotic therapy, or
progression in association with other sites of
disease upon the failure of treatment. One patient
in whom histological confirmation was not
obtained for the chest abnormalities died of
lymphoma during 'treatment. All the radiological
findings in this case were in agreement and were
assumed to represent a true positive.
False positive abnormalities Those initially thought
to be due to lymphoma, but subsequently shown on
clinical and radiological follow up not to represent
disease (see Results).
True negative investigations Those which were
normal at presentation and remained so at follow
up examination with no clinical evidence of disease
elsewhere.
False negative investigations Those which were
contradicted by other radiological findings which
fulfilled the true positive criteria.
Results
Comparison ofthe resultsfrom CXR, tomography
and CT scan
In all instances CT scan proved to be the most
sensitive and CXR the least sensitive method for
detecting intrathoracic lymphoma. The results of
conventional tomography were intermediate
between those of CXR and CT scan but never
significantly more sensitive than the CXR.
Tomography was therefore stopped after the first
50 patients (Table II).
Table II Comparison of CXR, tomography and CT scan
(50 patients)
True False True False
positive positive negative negative
Mediastinum
CXR 9 3 34 4
Tomogram 10 2 35 3
CT scan 13 0 37 0
Hilum
CXR 9 2 34 5
Tomogram 10 1 35 4
CT scan 13 2 34 1
The findings from CXR and CT scan differed
most significantly in the mediastinum (P<0.001 for
100 patients (Figure 1; Tables III and IV)). The
increased detection by the CT scan was particularlyCT SCANNING AND INTRATHORACIC LYMPHOMA 623
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Figure 1 Female age 24 with HD. (a) Normal CXR. (b) Small retrosternal mass of nodes.
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Table III Comparison of CXR
patients)
and CT scan (100
True False True False
positive positive negative negative
Mediastinum
CXR 26 4 57 13
CT scan 39 0 61 0
Hilum
CXR 26 4 63 7
CT scan 32 2 65 1
Parenchyma
CXR 11 0 85 4
CT scan 15 0 85 0
Pleural (69)
effusion
CXR 4 0 56 9
CT scan 13 0 56 0
evident for patients with NHL (16:7, CT
scan:CXR, Table V).
CT scan, although more sensitive than CXR, was
no more accurate at detecting hilar lymphadeno-
pathy than tomography (Table IV). This was due
to the difficulty experienced with all methods in
differentiating enlarged nodes from hilar vessels.
False positives in the mediastinum (Tables II and
III) were due to prominent vessels in all four cases
as shown by i.v. contrast enhancement of the CT
scans (Figure 2). Similarly at the hilum four of the
false positives were due to vessels and one, on
tomography, to a large anterior mediastinal mass
which was wrongly interpreted as involving the hila.
Pulmonary parenchymal disease was detected
with greater sensitivity by the CT scan compared
with the CXR (P<0.05, Table IV). All 4 patients in
whom CT scanning detected occult parenchymal
disease had NHL with no other evidence of extra-
nodal spread (Figure 3). Biopsy confirmation was
obtained in 2 of these 4 patients.
Intrathoracic lymphoma was found in 46/100
patients. The overall incidence of involvement by
site within the chest was: anterior mediastinum
37%, posterior mediastinum 11%, paratracheal
11 %, paraoesophageal 1%, carinal 1%, pericardiac
2%, parenchyma 15%, pleural effusion 13%, and
pleural plaques 4%. All those with parenchymal
disease has mediastinal or hilar lymphadenopathy
and all those with pleural invasion had extensive
disease within the chest.
Effect of CT scanning on staging and treatment
Thirty-nine patients had evidence of Stage IV
disease prior to CT scanning and thus neither stage
nor the treatment was affected by the CT scan.
There was a change in stage in 10/61 patients
with Stage I-III disease (16%) due to information
solely available from the CT scan. The stage was
increased in 9 patients: 4 from II-IV by the
detection of parenchymal deposits (2 confirmed on
biopsy), 3 from I-IT, and 2 from II-III by the
detection of intrathoracic lymphadenopathy. Stage
was decreased in one patient from III-I when the
CT scan demonstrated that a mediastinal shadow
was due to normal vascular structures.
Table IV Comparison ofresults by CXR, tomography and CT scan
Sensitivity
(True pos/True Pos+False Neg)
1-50 1-100
Specificity
(True Neg/True Neg+False Pos)
J-50 1-100
Mediastinum
CXR 69.2% 66.7% 91.9% 93.4%
Tomo 76.9 94.6
CT 100 100 100 100
Hilum
CXR 57.1 78.7 94.4 94.0
Tomo 71.4 97.2
CT 92.9 97.0 94.4 97.0
Parenchyma
CXR 73.3 - 100
CT 100 100
Sensitivity:
Mediastinum: CXR vs Tomo NS; Tomo vs CT P<0.05; CT vs CXR P<0.05 (0.001).
Hilum: CXR vs Tomo NS; Tomo vs CT NS; CT vs CXR P<0.05 (0.05).
Parencyma: CT vs CXR P<0.05.CT SCANNING AND INTRATHORACIC LYMPHOMA 625
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Figure 2 Male age 56 with NHL. (a) CXR: Wide upper mediastinum interpreted as lymphadenopathy. (b)
CT scan shows widely spaced normal vessels but no enlarged nodes.
L.
P-11:
E.,
R..:.
I626 C.J. GALLAGHER et al.
a
b
Figure 3 Female age 65 with NHL. (a) CXR: Enlarged L hilum but clear lung fields. (b) CT scan: Enlarged
L hilum with peripheral nodules confirmed as lymphoma.CT SCANNING AND INTRATHORACIC LYMPHOMA
Table V Comparison by histology of CXR and CT scan
Hodgkin's Disease
(37patients) True Pos False Pos True Neg False Neg
Mediastinum CXR 19 1 13 4
CT 23 0 14 0
Hilum CXR 13 1 19 4
CT 16 1 19 1
Parenchyma CXR 6 0 31 0
CT 6 0 31 0
Non Hodgkin Lymphoma
(63 patients)
Mediastinum CXR 7 3 44 9
CT 16 0 47 0
Hilum CXR 13 3 44 3
CT 16 1 46 0
Parenchyma CXR 5 0 54 4
CT 9 0 54 0
Thirty-two Stage 1-111 patients had either B
symptoms or very large intrathoracic masses for
which chemotherapy is our current treatment of
choice, and treatment was not therefore affected by
CT scan results. Treatment was changed in 11 of
the remaining 29 patients (38%). Four required
chemotherapy for parenchymal deposits and one
(downgraded from III to I) received involved field
radiotherapy for an inguinal deposit. Six other
patients receiving radiotherapy to the involved field
for NHL had the field changed by CT scanning
(includes one patient in whom the stage was not
changed). No change was made in those with
localised HD as all received mantle field radiation
which adequately covered any additional sites.
CTscanning and remission assessment (Table VI)
Complete remission was achieved by CXR criteria
in 28/46 patients with intrathoracic lymphoma,
although the CT scan returned to normal in only
18. There have been 9 relapses from the 28 with
normal CXR (32%) of which 6 were correctly
identified by the remission CT scan as having
residual disease after treatment. In comparison,
only 3/18 (17%) in whom the CT scan became
normal have relapsed.
However, a positive CT scan following treatment
did not always represent residual disease. Eight of
the 28 in whom the CT scan was still positive have
not relapsed in 2 years. A post treatment
laparotomy was performed in one patient (Figure
4) with marked residual abnormalities, but only
fibrotic and hylanised tissue was found.
Table VI CT scanning and remission assessment
Relapse/Progression
Radiology at remission at 2 years
CXR- CT- 18 3
CXR- CT+ 10 6
CXR+ CT+ 18 14
Discussion
With the introduction of any new staging technique
the two principal questions that must be answered
are: how does it compare with current practice and
what is the clinical relevance of any additional
findings? We have attempted to answer these
questions in a series of one hundred consecutive
and previously untreated patients as a
representative sample of our general lymphoma
practice.
The addition of CT scanning to the investigation
of the chest increased the frequency with which
intrathoracic lymphoma could be detected to 46%
in newly diagnosed patients, greater than hitherto
reported (Chabner et al., 1977; Filly et al., 1976;
Kaplan, 1980; Peckham, 1973; Rosenberg, 1961).
CT scan was shown to be the most sensitive
technique in the assessment of mediastinal and
parenchymal disease particularly in patients with
NHL but also in HD. However CT scan displayed
only a small advantage over CXR or tomography
at the hilum as has been found for other tumours
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Figure 4 Male age 34 with HD. (a) CT scan pretreatment: mass of paratracheal nodes. (b) CT scan post
treatment: residual R paratracheal mass offibrous tissue (conflrmed at thoracotomy).
within the chest (Fong et al., 1982; Muhm et al.,
1979; Osbourne et al., 1982; Underwood et al.,
1979; Baron et al., 1981). The low incidence of
pericardial and pleural infiltration reflects the early
stage in the disease at which most of these patients
had been diagnosed.
The additional information from CT scan
changed the stage in 10 patients and the treatment
in 11. The relative importance of these numbers,
however, becomes more apparent when the size of
the group "at risk" is taken into account; i.e.
change in stage 10/61 (16%), change in treatment
11/29 (38%). This compares favourably with the
yield from other staging procedures such as
lymphography or bone marrow biopsy (Chabner et
al., 1977; Kaplan, 1980).
The value of CT scanning at remission
assessment was more difficult to quantify,
particularly as relapse was the only positive
criterion available. The return of the CT scan toCT SCANNING AND INTRATHORACIC LYMPHOMA 629
normal was a better prognostic factor than CXR.
However, residual abnormalities on CT scan after
treatment did not always represent active disease, as
has been found at post treatment laparotomy
(Sutcliffe et al., 1982).
In conclusion, the greater sensitivity and
specificity of the chest CT scan produced changes
in staging and treatment which were most relevant
to the management of those patients with localised
disease or only minor abnormalities by
conventional chest radiology. Further follow up will
be necessary to assess the relevance of CT scan at
remission assessment. The difficulty in providing a
CT scanning service for the routine staging of these
patients with malignant lymphoma argues for the
greater concentration of lymphoma treatment in
specialist centres.
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